Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Sexually Transmitted Diseases

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 42 articles:
HTML format



Single Articles


    February 2020
  1. PHUMAPHI J, Gautam KC, Mason E
    Increased production and comprehensive guidelines needed for HPV vaccine.
    Lancet. 2020;395:319-321.
    PubMed    


  2. THE LANCET
    Eliminating cervical cancer.
    Lancet. 2020;395:312.
    PubMed    


    January 2020
  3. BRISSON M, Kim JJ, Canfell K, Drolet M, et al
    Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Lancet. 2020 Jan 30. pii: S0140-6736(20)30068.
    PubMed     Abstract available


  4. TSU VD
    Cervical cancer elimination: are targets useful?
    Lancet. 2020 Jan 30. pii: S0140-6736(20)30219.
    PubMed    


  5. CANFELL K, Kim JJ, Brisson M, Keane A, et al
    Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Lancet. 2020 Jan 30. pii: S0140-6736(20)30157.
    PubMed     Abstract available


  6. BROTONS M, Bruni L
    Population-level impact of human papillomavirus vaccination.
    Lancet. 2020 Jan 20. pii: S0140-6736(19)33153.
    PubMed    


  7. SASIENI P, Cuzick J
    Population-level impact of human papillomavirus vaccination.
    Lancet. 2020 Jan 20. pii: S0140-6736(19)33109.
    PubMed    


  8. DROLET M, Brisson M
    Population-level impact of human papillomavirus vaccination - Authors' reply.
    Lancet. 2020 Jan 20. pii: S0140-6736(19)33158.
    PubMed    


    June 2019
  9. DE SANJOSE S, Delany-Moretlwe S
    HPV vaccines can be the hallmark of cancer prevention.
    Lancet. 2019 Jun 26. pii: S0140-6736(19)30549.
    PubMed    


  10. DROLET M, Benard E, Perez N, Brisson M, et al
    Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
    Lancet. 2019 Jun 26. pii: S0140-6736(19)30298.
    PubMed     Abstract available


    May 2019
  11. LECHNER M, Breeze CE, O'Mahony JF, Masterson L, et al
    Early detection of HPV-associated oropharyngeal cancer.
    Lancet. 2019;393:2123.
    PubMed    


  12. GRAHAM D, Prue G, Baker P, Nutting C, et al
    Early detection of HPV-associated oropharyngeal cancer-Authors' reply.
    Lancet. 2019;393:2123-2124.
    PubMed    


  13. KIRKCALDY RD, Workowski KA
    Gentamicin as an alternative treatment for gonorrhoea.
    Lancet. 2019 May 2. pii: S0140-6736(19)30244.
    PubMed    


  14. ROSS JDC, Brittain C, Cole M, Dewsnap C, et al
    Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
    Lancet. 2019 May 2. pii: S0140-6736(18)32817.
    PubMed     Abstract available


    March 2019
  15. ZHAO F, Qiao Y
    Cervical cancer prevention in China: a key to cancer control.
    Lancet. 2019;393:969-970.
    PubMed    


    January 2019
  16. COHEN PA, Jhingran A, Oaknin A, Denny L, et al
    Cervical cancer.
    Lancet. 2019;393:169-182.
    PubMed     Abstract available


  17. THE LANCET
    Cervical cancer: unequal progress.
    Lancet. 2019;393:104.
    PubMed    


  18. OOSTHUIZEN JC, Doody J
    De-intensified treatment in human papillomavirus-positive oropharyngeal cancer.
    Lancet. 2019;393:5-7.
    PubMed    


  19. GILLISON ML, Trotti AM, Harris J, Eisbruch A, et al
    Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.
    Lancet. 2019;393:40-50.
    PubMed     Abstract available


    November 2018
  20. MEHANNA H, Robinson M, Hartley A, Kong A, et al
    Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.
    Lancet. 2018 Nov 15. pii: S0140-6736(18)32752.
    PubMed     Abstract available


    October 2018
  21. HOCKING JS, Temple-Smith M, Guy R, Donovan B, et al
    Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial.
    Lancet. 2018;392:1413-1422.
    PubMed     Abstract available


  22. ADAMSON PC, Klausner JD
    No benefit of chlamydia screening in primary care?
    Lancet. 2018;392:1381-1383.
    PubMed    


  23. THE LANCET
    Congenital syphilis in the USA.
    Lancet. 2018;392:1168.
    PubMed    


    September 2018
  24. PRUE G, Baker P, Graham D, Nutting C, et al
    It is time for universal HPV vaccination.
    Lancet. 2018;392:913-914.
    PubMed    


  25. BURKI T
    Cochrane review methods called into question.
    Lancet. 2018;392:906.
    PubMed    


    August 2018
  26. GREEN A
    HPV vaccine to be offered to boys in England.
    Lancet. 2018;392:374.
    PubMed    


    May 2018
  27. CORCORAN B, Clarke A, Barrett T
    Rapid response to HPV vaccination crisis in Ireland.
    Lancet. 2018;391:2103.
    PubMed    


    April 2018
  28. BARNETT R
    Syphilis.
    Lancet. 2018;391:1471.
    PubMed    


    March 2018
  29. WATTS G
    New York Challenge sets high bar for HPV vaccination.
    Lancet. 2018;391:1137.
    PubMed    


    February 2018
  30. LARSON HJ
    A global girl gang.
    Lancet. 2018;391:527-528.
    PubMed    


    December 2017
  31. MASTERSON L, O'Mahony J, Lechner M
    Expanding the benefits of HPV vaccination to boys and men.
    Lancet. 2017;388:2992.
    PubMed    


    November 2017
  32. MABEY D, Marks M, Peeling R, Lawn J, et al
    Stillbirth caused by syphilis remains a major global health problem.
    Lancet. 2017;390:2036.
    PubMed    


  33. HEININGER U
    Syphilis in children.
    Lancet. 2017;390:2035-2036.
    PubMed    


    October 2017
  34. YIN Y
    HPV vaccination in China needs to be more cost-effective.
    Lancet. 2017;390:1735-1736.
    PubMed    


    September 2017
  35. DENNY L
    Nine-valent human papillomavirus vaccine: great science, but will it save lives?
    Lancet. 2017 Sep 5. pii: S0140-6736(17)32144.
    PubMed    


  36. HUH WK, Joura EA, Giuliano AR, Iversen OE, et al
    Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
    Lancet. 2017 Sep 5. pii: S0140-6736(17)31821.
    PubMed     Abstract available


    July 2017
  37. THE LANCET
    Curbing the rise in gonococcal AMR.
    Lancet. 2017;390:204.
    PubMed    


    April 2017
  38. THE LANCET
    Syphilis: an ancient disease in a modern era.
    Lancet. 2017;389:1492.
    PubMed    


    December 2016
  39. HOOK EW RD
    Syphilis.
    Lancet. 2016 Dec 16. pii: S0140-6736(16)32411.
    PubMed     Abstract available


    November 2016
  40. DENNY L, de Sanjose S, Mutebi M, Anderson BO, et al
    Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries.
    Lancet. 2016 Nov 1. pii: S0140-6736(16)31795.
    PubMed     Abstract available


    October 2016
  41. WONG NS, Huang S, Chen L, Zhao P, et al
    Spatiotemporal clusters of primary and secondary syphilis cases in south China: an observational study.
    Lancet. 2016;388 Suppl 1:S90.
    PubMed     Abstract available


  42. TANG S, Tang W, Meyers K, Chan P, et al
    HIV and syphilis among men who have sex with men and transgender individuals in China: a scoping review.
    Lancet. 2016;388 Suppl 1:S74.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: